?2-agonists (LABA): Bambuterol • the effects of combivent • Formoterol • Salmeterolother: Epinephrine • Isoproterenol • OrciprenalineGlucocorticoids Beclometasone • Budesonide • Ciclesonide • Fluticasone • MometasoneAnticholinergics Ipratropium • TiotropiumMast cell stabilizers Cromoglicate • NedocromilXanthines.

from Combivent)Jump to: navigation, searchIpratropium/salbutamolCombination ofIpratropium Muscarinic antagonistSalbutamol Short-acting ?2-adrenergic agonistIdentifiersCAS number the effects of combivent ?ATC code ?PubChem ?Therapeutic considerationsPregnancy cat. ?Legal statusRoutes InhalationThe combination preparation ipratropium/salbutamol is a formulation containing ipratropium bromide and salbutamol sulfate (albuterol sulfate) used in the management of chronic obstructive the effects of combivent disease (COPD) and asthma. It is marketed by Boehringer Ingelheim as metered dose inhaler (MDI) and nebuliser preparations under the trade name Combivent.[hide]v • d • eDrugs for obstructive airway diseases: asthma/COPD the effects of combivent inhalants Short acting ?2-agonists: Salbutamol/Levosalbutamol • the effects of combivent • TerbutalineLong acting ?2-agonists (LABA): the effects of combivent • Clenbuterol • Formoterol the effects of combivent Salmeterolother: Epinephrine • Isoproterenol • OrciprenalineGlucocorticoids Beclometasone • Budesonide • Ciclesonide • Fluticasone Ciclesonide.

inhalants Short acting ?2-agonists: Salbutamol/Levosalbutamol • Fenoterol • TerbutalineLong acting ?2-agonists (LABA): Bambuterol ?2-agonists.